John Rim, Samsung Biologics CEO (Samsung/PR Newswire)

Up­dat­ed: Sam­sung Bi­o­log­ics spells out ex­pan­sion plans in South Ko­rea and US

The CD­MO arm of one of South Ko­rea’s largest con­glom­er­ates has post­ed its year-end re­sults and plans for 2023, which in­clude new con­struc­tion.

Sam­sung Bi­o­log­ics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.